Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2083080 | Drug Discovery Today: Therapeutic Strategies | 2006 | 4 Pages |
Abstract
Evidence suggests that current antidepressants increase the number of new neurons. This suggests robust activators of the process might be more effective antidepressants. Stress plays a role in depression and decreases the rate of neurogenesis. Does decreased neurogenesis cause a depressed state or simply often accompany this condition? We review animal studies, which suggest that the latter may be the case, making this a less attractive target for new therapies.
Section editors:David Sibley – National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, USAC. Anthony Altar – Psychiatric Genomics, Gaithersburg, USATheresa Branchek – Lundbeck Research, Paramus, USA
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Fritz A. Henn, Barbara Vollmayr,